Long-term effects of heroin-assisted treatment in Germany.
about
Critical remarks on strategies aiming to reduce drug related harm: substance misuse and HIV/AIDS in a world in turmoil.Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatmentThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Heroin maintenance treatment: from idea to research to practice.Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania.A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trialBAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysisThe North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.The science and practice of medication-assisted treatments for opioid dependence.Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.The right medicine for World Drug Day.Harm reduction--from a conceptual framework to practical experience: the example of Germany.Collaborative Efforts With Opioid Users to Promote Competence and Voluntariness in Clinical Trials With Injectable Opioid Assisted Treatment.Our Life Depends on This Drug: Competence, Inequity, and Voluntary Consent in Clinical Trials on Supervised Injectable Opioid Assisted Treatment.Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China.Epigenetic Regulation of the Promotor Region of Vascular Endothelial Growth Factor-A and Nerve Growth Factor in Opioid-Maintained Patients.The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence.Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study
P2860
Q30382125-DBEEE614-6610-40BD-B7ED-07A9C3C7C99BQ33582025-95C79841-49A7-4B4D-968A-869551B48F47Q33781890-7D859733-093E-49C7-B5C2-44BFBC3A9C83Q33870389-04BADAC2-42F1-4907-BE4B-5EB5FD30D91AQ34168596-075544E2-C11F-4400-A448-AE9EF1E0501CQ34216585-1FD60DA8-2D37-4120-B514-806E25E48C33Q34263515-DC1684F8-EF4E-4F19-B7E3-A15C88A2646CQ34274002-BBE429BB-3082-47BC-95AB-65FE533B1176Q34277168-E41F6C27-2400-4B80-9871-B90EAABDB144Q34901860-328CF75F-42F0-4B84-9C45-F0CC5789E45EQ36985312-AF8B65BC-DDB5-41D5-9E25-97D4BC47B436Q37366195-9BC4DF65-F3A8-448B-955B-4C836D50797AQ37452336-B842CC94-D96B-48D9-84D4-C047F4B09F28Q39223925-6AD7EF62-5DC5-44E8-B494-B4F02622FAD5Q42597304-9F55403F-E105-4CD9-BDB5-5ECD2DFF41F3Q43235351-AF620732-6BC4-49E0-82E2-3BA6D1DFBC19Q44229780-7B23F781-AF1D-4F6D-AFCE-0E3B63C62145Q44351099-58916353-613F-431C-B498-AD4F9BC682EEQ44351104-612EB0AC-0517-4B16-84FF-E6658B1B25DEQ45730112-0CC69C29-B943-4E89-A864-4A87FCBD40C5Q47566004-F4B914F4-A696-4C17-8053-C5F4032F209BQ48686580-E3EAEA55-9B8B-4BEC-8310-652B72F910F9Q52297943-1C25D5B3-3363-407D-8601-E8F5E6F04A71Q58242031-0A0EA4C9-FEDD-4E9D-B120-CF8CB17FCC3B
P2860
Long-term effects of heroin-assisted treatment in Germany.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Long-term effects of heroin-assisted treatment in Germany.
@ast
Long-term effects of heroin-assisted treatment in Germany.
@en
Long-term effects of heroin-assisted treatment in Germany.
@nl
type
label
Long-term effects of heroin-assisted treatment in Germany.
@ast
Long-term effects of heroin-assisted treatment in Germany.
@en
Long-term effects of heroin-assisted treatment in Germany.
@nl
prefLabel
Long-term effects of heroin-assisted treatment in Germany.
@ast
Long-term effects of heroin-assisted treatment in Germany.
@en
Long-term effects of heroin-assisted treatment in Germany.
@nl
P2093
P1433
P1476
Long-term effects of heroin-assisted treatment in Germany.
@en
P2093
Christian Haasen
Christoph Dilg
Karin Bonorden-Kleij
Mario Vogel
Michael Soyka
Peter Degkwitz
Sabine Tanger
Torsten Passie
Uwe Verthein
Wilfried K Köhler
P304
960-6; discussion 967-8
P356
10.1111/J.1360-0443.2008.02185.X
P407
P577
2008-04-16T00:00:00Z